These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10436961)

  • 1. [The antibacterial activity of cefmetazole and other antibiotics to 463 isolates].
    Xu Y; Wang H; Chen M
    Zhonghua Nei Ke Za Zhi; 1997 Aug; 36(8):540-2. PubMed ID: 10436961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory and bactericidal activity of cefmetazole and seven other beta-lactams against different bacterial inocula.
    Esposito S; Galante D; Barba D
    Chemioterapia; 1986 Apr; 5(2):101-4. PubMed ID: 3518963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibacterial activity of cefmenoxime against clinical isolates. Comparative study].
    Takahashi C; Miyazawa K
    Jpn J Antibiot; 1985 Jan; 38(1):27-30. PubMed ID: 3886949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):567-71. PubMed ID: 3534744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal activity of cefazolin, cefoxitin, and cefmetazole against Escherichia coli and Klebsiella pneumoniae.
    Goto S; Sakamoto H; Ogawa M; Tsuji A; Kuwahara S
    Chemotherapy; 1982; 28(1):18-25. PubMed ID: 7035088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antibacterial activity of ceftizoxime against gram-negative strains.
    Debbia E; Soro O
    Chemioterapia; 1985 Apr; 4(2):166-9. PubMed ID: 3891115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infections of cefotaxime-resistant and cefmetazole-susceptible Escherichia coli and Klebsiella pneumoniae in children.
    Wu TZ; Hsueh PR; Chang LY; Lu CY; Wang CY; Yang CY; Shao PL; Lee PI; Lee CY; Huang LM
    J Microbiol Immunol Infect; 2005 Apr; 38(2):112-6. PubMed ID: 15843855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefmetazole: a broad spectrum cephem antibiotic effective on methicillin- and cephem-resistant Staphylococcus aureus.
    Yokota T; Yoshida R; Utsui Y; Tajima M
    Drugs Exp Clin Res; 1985; 11(1):29-38. PubMed ID: 3915273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro susceptibility of Escherichia coli and Klebsiella sp. to antibiotics].
    Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y
    Jpn J Antibiot; 1990 Apr; 43(4):659-69. PubMed ID: 2199690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Susceptibility of bacteria to selected cephalosporins of the II and III generation].
    Nowakowska K; Szozda G; Pawluch D; Drejewicz H; Siwińska-Gołebiowska H
    Med Dosw Mikrobiol; 1993; 45(2):177-82. PubMed ID: 8309293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bactericidal kinetics of cefazolin, cefoxitin and amikacin alone and in combination (author's transl)].
    Shah PM; Stille W
    Arzneimittelforschung; 1978; 28(9):1539-41. PubMed ID: 383106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
    Duttaroy B; Mehta S
    Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
    Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
    Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
    Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro activity of cefoxitin, a new cephalosporin (author's transl)].
    Shah PM; Zwischenbrugger H; Stille W
    MMW Munch Med Wochenschr; 1976 Nov; 118(45):1469-72. PubMed ID: 825763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
    Verbist L
    Arzneimittelforschung; 1981; 31(6):982-6. PubMed ID: 6266430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
    Thabaut A; Meyran M; Huerre M
    Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.